menu
    • menu

    Company profile for Coherus Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Coherus Bioscience is a leading developer of high-quality biosimilar therapeutics. Our team is comprised of successful veterans who helped pioneer the biologic industry. We have all joined together and are driven by a common mission: improving patient benefit by expanding access to biologic drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Coherus BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    333 Twin Dolphin Drive Suite 600 Redwood City, CA 94065
    Telephone
    Telephone
    1 800-794-5434
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.coherus.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/coherus-biosciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/coherus_bio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Coherus & Storm therapeutics to Test STC-15 + LOQTORZI in Combo
    Coherus & Storm therapeutics to Test STC-15 + LOQTORZI in Combo

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088627/33333/en/Coherus-Announces-Clinical-Collaboration-with-STORM-Therapeutics-to-Evaluate-STC-15-in-Combination-with-LOQTORZI-toripalimab-tpzi.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Coherus BioSciences Reports Q1 2025 Results and Business Update
    Coherus BioSciences Reports Q1 2025 Results and Business Update

    12 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/12/3079578/33333/en/Coherus-BioSciences-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 May 2025
    Share Share
    Coherus to Report Q1 2025 Financial Results on May 12, 2025
    Coherus to Report Q1 2025 Financial Results on May 12, 2025

    05 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/05/3074482/33333/en/Coherus-to-Report-First-Quarter-2025-Financial-Results-on-May-12-2025.html

    GLOBENEWSWIRE
    05 May 2025
    Share Share
    Coherus to Participate in Upcoming Investor Conferences
    Coherus to Participate in Upcoming Investor Conferences

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072917/33333/en/Coherus-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share
    Coherus presents early data from CHS-114 study at AACR 2025
    Coherus presents early data from CHS-114 study at AACR 2025

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069362/33333/en/Coherus-Presents-Promising-Early-Clinical-Data-from-Phase-1-Dose-Expansion-Study-of-CHS-114-in-Patients-with-Recurrent-Metastatic-Head-and-Neck-Squamous-Cell-Carcinoma-at-AACR-2025.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Coherus loses commercial chief amid exit from biosimilar space
    Coherus loses commercial chief amid exit from biosimilar space

    24 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercepharma.com/marketing/coherus-commercial-chief-leaves-amid-exit-biosimilar-space

    FIERCE BIOTECH
    24 Apr 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search